The Nature of Pharmaceutical Competition: Implications for Antitrust Analysis
Richard G. Frank and
Raymond S. Hartman
International Journal of the Economics of Business, 2015, vol. 22, issue 2, 301-343
Abstract:
Competition among alternative pharmaceutical products occurs within therapeutic areas and is importantly conditioned upon whether it occurs among therapeutic substitutes (alternative molecules - differentiated products) or within a particular molecule (a brand-name drug and its generic substitutes - homogeneous products). Healthcare institutions treat substitution among brand-name and generic drugs differently. Hence, competition among therapeutic substitutes may be considerably different from competition between a brand-name drug and its generics. We address these distinct competitive behaviors in the context of an active antitrust issue - foreclosure of generic entry. We empirically examine the contours of the relevant antitrust markets in two ways. We use the hypothetical monopolist test of the DOJ Merger Guidelines , and we conduct exemplar empirical analyses for two therapies (alpha blockers and antidepressants). We demonstrate that price competition occurs primarily at the level of the molecule. Our work provides a general framework for analyzing and defining antitrust markets in the pharmaceutical industry.
Date: 2015
References: View complete reference list from CitEc
Citations:
Downloads: (external link)
http://hdl.handle.net/10.1080/13571516.2015.1045745 (text/html)
Access to full text is restricted to subscribers.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:taf:ijecbs:v:22:y:2015:i:2:p:301-343
Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/CIJB20
DOI: 10.1080/13571516.2015.1045745
Access Statistics for this article
International Journal of the Economics of Business is currently edited by Eleanor Morgan
More articles in International Journal of the Economics of Business from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().